Called montelukast, the drug, approved by the US Food and Drug Administration (FDA), has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever, and hives.
Read More »New nano-composite to beat antimicrobial resistance
New Delhi, Sep 10: The battle against antimicrobial resistance is set to get a major boost with researchers from the Indian Institute of Technology (IIT)-Roorkee and Bengaluru-based startup Log 9 Materials Scientific Pvt. Ltd., developing a new non-toxic antibacterial and antibiofilm composite. What Are Bacterial biofilms? Bacterial biofilms are notorious …
Read More »‘Mulethi’ may help alleviate aggressive symptoms of COVID-19
Herbal drug against COVID-19 New Delhi, June 30 : In an interesting development, a team of scientists at the Government of India’s Department of Biotechnology (DBT)’s National Brain Research Centre (NBRC), has identified Mulethi, a commonly used herb, as a potential source for the development of a drug against COVID-19. Scientists have found that …
Read More »Immune cell metabolism altered in ME/CFS
Some immune cells in people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) show disruptions in the way they produce and use energy.
Read More »Peanut allergy protection limited after oral immunotherapy : Study
Food allergy affects up to approximately 8% of children and 4% of adults in the United States. When you have a food allergy, your body’s defense system
Read More »